86 European, US children down with severe hepatitis; experts perplexed
Some have cited COVID-19 as a reason; some two years of it, while the rest have blamed the adenovirus
Activists demand access to affordable oral hepatitis drugs
Giving patents to foreign-made medicines will add to patients’ woes, they urge